Zilbrysq 16
Zilbrysq 16 is a medicine authorised by Swissmedic under authorisation number 69066. The authorisation holder is UCB-Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 30 August 2024 and the authorisation is limited until 29 August 2029. ATC code L04AJ06 places the medicine in the group Immunosuppressants.
| Authorisation number | 69066 |
|---|---|
| Name | Zilbrysq 16 |
| Full name | Zilbrysq 16,6 mg, solution pour injection en seringue pré-remplie |
| Authorisation holder | UCB-Pharma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L04AJ06 |
| First authorisation | 30 August 2024 |
| Authorisation validity | 29 August 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Zilbrysq 16,6 mg, solution pour injection en seringue pré-remplie | A | 30 August 2024 |
| 2 | Zilbrysq 23 mg, solution pour injection en seringue pré-remplie | A | 30 August 2024 |
| 3 | Zilbrysq 32,4 mg, solution pour injection en seringue pré-remplie | A | 30 August 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 7 | Fertigspritze(n) | L04AJ06 | 07.15.0. | A |
| 2 | 7 | Fertigspritze(n) | L04AJ06 | 07.15.0. | A |
| 3 | 7 | Fertigspritze(n) | L04AJ06 | 07.15.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Zilbrysq 16 authorised in Switzerland?
Yes. Zilbrysq 16 is authorised by Swissmedic under authorisation number 69066, data as of 01 September 2026. The authorisation is limited until 29 August 2029.
Which dispensing category does Zilbrysq 16 have?
Zilbrysq 16 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Zilbrysq 16?
The authorisation holder is UCB-Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.